EMEA-002282-PIP01-17-M01
Key facts
| Active substance |
Molgramostim
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0509/2021
|
| PIP number |
EMEA-002282-PIP01-17-M01
|
| Pharmaceutical form(s) |
Nebuliser solution
|
| Condition(s) / indication(s) |
Treatment of pulmonary alveolar proteinosis
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
Savara ApS
Email: charles.lapree@savarapharma.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|